Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#40 / 109 Total
FENC - Fennec Pharmaceuticals Inc - Stock Price Chart
TickerFENC [NASD, RUT]
CompanyFennec Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap242.50MEPS (ttm)-0.51
P/E-EPS this Y-
Forward P/E9.91EPS next Y392.22%
PEG-EPS past 5Y52.21%
P/S7.85EPS next 5Y-
P/B-EPS Q/Q-110.22%
Dividend-Sales Q/Q-65.52%
Insider Own16.61%Inst Own57.71%
Insider Trans-1.38%Inst Trans-3.43%
Short Float5.67%EarningsMay 13/b
Analyst Recom1.00Target Price13.80
Avg Volume81.55K52W Range3.96 - 9.11
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RALLIS CHRIS ADirectorJul 07 '25Option Exercise2.352,1274,99855,911Jul 07 05:31 PM
RALLIS CHRIS ADirectorJul 07 '25Sale8.711,1199,74654,792Jul 07 05:31 PM
Raykov RostyDirectorJul 03 '25Sale8.6110,00086,10060,670Jul 07 04:30 PM
ROSTISLAV RAYKOVDirectorJul 03 '25Proposed Sale8.6110,00086,102Jul 03 02:01 PM
Raykov RostyDirectorJun 05 '25Sale7.7810,00077,80065,462Jun 06 04:20 PM
NVDA - NVIDIA Corp - Stock Price Chart
TickerNVDA [NASD, DJIA, NDX, S&P 500]
CompanyNVIDIA Corp
CountryUSA
IndustrySemiconductors
Market Cap4024.05BEPS (ttm)3.10
P/E53.12EPS this Y44.57%
Forward P/E28.75EPS next Y32.68%
PEG1.76EPS past 5Y91.83%
P/S27.10EPS next 5Y30.17%
P/B47.97EPS Q/Q27.60%
Dividend0.02%Sales Q/Q69.18%
Insider Own4.07%Inst Own66.35%
Insider Trans-0.51%Inst Trans1.06%
Short Float1.04%EarningsMay 28/a
Analyst Recom1.37Target Price174.26
Avg Volume214.71M52W Range86.62 - 164.50
Jul-10-25Initiated Goldman Buy $185
NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEAWELL A BROOKEDirectorJul 11 '25Proposed Sale166.2848,1127,999,984Jul 11 04:58 PM
HUANG JEN HSUNOfficerJul 11 '25Proposed Sale166.0075,00012,450,159Jul 11 04:54 PM
HUANG JEN HSUNPresident and CEOJul 10 '25Sale163.2675,00012,244,38574,798,225Jul 10 07:30 PM
HUANG JEN HSUNPresident and CEOJul 09 '25Sale163.1175,00012,233,61674,873,225Jul 10 07:30 PM
HUANG JEN HSUNPresident and CEOJul 08 '25Sale159.3675,00011,952,01374,948,225Jul 10 07:30 PM
NNNN - Anbio Biotechnology - Stock Price Chart
TickerNNNN [NASD]
CompanyAnbio Biotechnology
CountryGermany
IndustryMedical Instruments & Supplies
Market Cap7.09BEPS (ttm)0.06
P/E812.87EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S800.91EPS next 5Y-
P/B117.02EPS Q/Q-267.38%
Dividend-Sales Q/Q-36.00%
Insider Own9.57%Inst Own0.15%
Insider Trans0.00%Inst Trans310.54%
Short Float0.54%Earnings-
Analyst Recom-Target Price-
Avg Volume95.14K52W Range5.18 - 52.62
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.
SPPP - Sprott Physical Platinum and Palladium Trust - Stock Price Chart
TickerSPPP [NYSE]
CompanySprott Physical Platinum and Palladium Trust
CountryCanada
IndustryAsset Management
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume747.40K52W Range8.69 - 12.46
Sprott Physical Platinum and Palladium Trust is an exchange traded commodity launched and managed by Sprott Asset Management, LP. The fund invests in commodity markets. It invests in physical platinum and palladium bullion in Good Delivery plate or ingot form. Sprott Physical Platinum and Palladium Trust was formed on December 23, 2011 and is domiciled in Canada.
COIN - Coinbase Global Inc - Stock Price Chart
TickerCOIN [NASD, S&P 500]
CompanyCoinbase Global Inc
CountryUSA
IndustryFinancial Data & Stock Exchanges
Market Cap98.59BEPS (ttm)5.34
P/E72.53EPS this Y-45.39%
Forward P/E50.46EPS next Y48.17%
PEG-EPS past 5Y-
P/S14.26EPS next 5Y-1.84%
P/B9.41EPS Q/Q-94.50%
Dividend-Sales Q/Q-13.50%
Insider Own20.70%Inst Own46.47%
Insider Trans-1.95%Inst Trans-0.01%
Short Float6.94%EarningsJul 31/a
Analyst Recom2.30Target Price306.53
Avg Volume13.04M52W Range142.58 - 389.16
Jul-10-25Downgrade H.C. Wainwright Buy → Sell $300
Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brian ArmstrongOfficerJul 11 '25Proposed Sale387.0627,75110,741,302Jul 11 04:44 PM
Armstrong BrianChairman and CEOJul 01 '25Sale338.2925,0008,457,278526Jul 03 01:33 PM
Grewal PaulChief Legal OfficerJul 02 '25Option Exercise26.2610,000262,60092,328Jul 03 01:32 PM
Grewal PaulChief Legal OfficerJul 02 '25Sale348.6410,0003,486,43382,328Jul 03 01:32 PM
Brian ArmstrongOfficerJul 01 '25Proposed Sale335.3325,0008,383,250Jul 01 04:53 PM
TEL - TE Connectivity plc - Stock Price Chart
TickerTEL [NYSE, S&P 500]
CompanyTE Connectivity plc
CountryIreland
IndustryElectronic Components
Market Cap52.52BEPS (ttm)4.56
P/E38.82EPS this Y9.09%
Forward P/E19.51EPS next Y10.07%
PEG3.70EPS past 5Y12.73%
P/S3.28EPS next 5Y10.48%
P/B4.35EPS Q/Q-97.52%
Dividend1.54%Sales Q/Q4.44%
Insider Own0.17%Inst Own92.58%
Insider Trans-30.16%Inst Trans-0.92%
Short Float1.62%EarningsJul 23/b
Analyst Recom1.76Target Price179.69
Avg Volume1.76M52W Range116.30 - 175.31
Jul-11-25Upgrade Citigroup Neutral → Buy $200
TE Connectivity Plc is a company that engages in the provision of connectivity and sensor solutions for the purpose of distribution of power, signal, and data. It operates under the following segments: Transportation solutions, Industrial solutions, and Communications solutions. The company was founded in 2007 and is headquartered in Galway, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stucki Aaron KylePres. Transportation SolutionsJun 26 '25Option Exercise93.3613,1001,223,01636,757Jun 27 10:05 AM
Stucki Aaron KylePres. Transportation SolutionsJun 26 '25Sale170.0013,1002,227,00023,657Jun 27 10:05 AM
AARON K STUCKIOfficerJun 26 '25Proposed Sale170.0013,1002,227,000Jun 26 04:55 PM
Kroeger Shadrak WPres., Industrial SolutionsJun 02 '25Option Exercise80.2025,0002,005,01050,976Jun 03 11:04 AM
Kroeger Shadrak WPres., Industrial SolutionsJun 02 '25Sale159.0325,0003,975,73625,976Jun 03 11:04 AM
AMLX - Amylyx Pharmaceuticals Inc - Stock Price Chart
TickerAMLX [NASD, RUT]
CompanyAmylyx Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap684.60MEPS (ttm)-3.10
P/E-EPS this Y60.08%
Forward P/E-EPS next Y19.09%
PEG-EPS past 5Y-78.71%
P/S-EPS next 5Y30.27%
P/B3.40EPS Q/Q76.07%
Dividend-Sales Q/Q-100.00%
Insider Own26.74%Inst Own80.20%
Insider Trans-0.45%Inst Trans110.11%
Short Float10.14%EarningsMay 08/b
Analyst Recom1.11Target Price11.62
Avg Volume1.35M52W Range1.76 - 7.61
Jul-10-25Resumed Goldman Buy $10
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRATES JAMES MChief Financial OfficerMar 31 '25Sale3.4710,89637,806290,988Apr 02 05:22 PM
Bedrosian Camille LChief Medical OfficerMar 31 '25Sale3.4712,42543,082194,375Apr 02 05:14 PM
Mazzariello GinaChief Legal OfficerMar 31 '25Sale3.489,19231,954187,969Apr 02 05:12 PM
Cohen Joshua BCo-Chief Executive OfficerMar 31 '25Sale3.4721,49074,4823,355,280Apr 02 04:57 PM
Klee Justin B.Co-Chief Executive OfficerMar 31 '25Sale3.4621,49074,4543,355,276Apr 02 04:52 PM
ZVRA - Zevra Therapeutics Inc - Stock Price Chart
TickerZVRA [NASD, RUT]
CompanyZevra Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap685.14MEPS (ttm)-1.89
P/E-EPS this Y182.60%
Forward P/E19.97EPS next Y-66.68%
PEG-EPS past 5Y29.64%
P/S16.88EPS next 5Y-
P/B16.70EPS Q/Q85.60%
Dividend-Sales Q/Q495.65%
Insider Own1.18%Inst Own65.35%
Insider Trans-16.77%Inst Trans6.85%
Short Float9.24%EarningsMay 13/a
Analyst Recom1.00Target Price23.86
Avg Volume702.29K52W Range5.45 - 12.37
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson RahsaanChief Legal & ComplianceJun 26 '25Sale9.2124,000221,00442,666Jun 30 05:02 PM
RAHSAAN THOMPSONOfficerJun 26 '25Proposed Sale9.3324,000223,920Jun 26 04:25 PM
Watton Corey MichaelDirectorMar 28 '25Buy7.843002,3521,800Mar 31 08:05 PM
Bode John BDirectorMar 19 '25Buy7.9610,00079,62440,000Mar 21 04:06 PM
Sangiovanni Timothy J.SVP, Finance & Corp ControllerFeb 13 '25Sale7.863,00023,58816,341Feb 14 05:57 PM
PARR - Par Pacific Holdings Inc - Stock Price Chart
TickerPARR [NYSE, RUT]
CompanyPar Pacific Holdings Inc
CountryUSA
IndustryOil & Gas Refining & Marketing
Market Cap1.81BEPS (ttm)-1.12
P/E-EPS this Y70.92%
Forward P/E13.69EPS next Y305.03%
PEG-EPS past 5Y-
P/S0.23EPS next 5Y89.87%
P/B1.65EPS Q/Q-789.15%
Dividend-Sales Q/Q-11.90%
Insider Own5.17%Inst Own96.84%
Insider Trans0.00%Inst Trans-3.45%
Short Float5.92%EarningsMay 06/a
Analyst Recom2.12Target Price27.12
Avg Volume1.46M52W Range11.86 - 34.82
Par Pacific Holdings, Inc. engages in the operation of energy and infrastructure businesses. It operates through the following segments: Refining, Retail, Logistics, and Other. The Refining segment produces ultra-low sulfur diesel, gasoline, jet fuel, marine fuel, low sulfur fuel oil, and other associated refined products. The Retail segment sells gasoline, diesel, and retail merchandise. The Logistics segment is involved in terminals, pipelines, a single-point mooring, and trucking operations to distribute refined products throughout the islands of Oahu, Maui, Hawaii, Molokai, and Kauai. The company was founded on December 21, 1984 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHASE ANTHONY RFormer DirectorJan 31 '25Proposed Sale16.7514,235238,468Jan 31 05:13 PM
Monteleone WilliamPresident and CEODec 16 '24Option Exercise14.6027,740405,004383,881Dec 17 04:34 PM
Monteleone WilliamPresident and CEODec 16 '24Sale15.8126,507419,076357,374Dec 17 04:34 PM
Monteleone WilliamOfficerDec 16 '24Proposed Sale15.8126,507419,003Dec 16 04:19 PM
PATE WILLIAMDirectorDec 12 '24Option Exercise14.6071,9181,050,003592,310Dec 13 08:02 PM
ANSS - Ansys Inc - Stock Price Chart
TickerANSS [NASD, NDX, S&P 500]
CompanyAnsys Inc
CountryUSA
IndustrySoftware - Application
Market Cap32.93BEPS (ttm)6.74
P/E55.60EPS this Y5.32%
Forward P/E29.35EPS next Y11.04%
PEG7.95EPS past 5Y4.51%
P/S12.75EPS next 5Y6.99%
P/B5.33EPS Q/Q48.54%
Dividend-Sales Q/Q8.21%
Insider Own0.42%Inst Own90.92%
Insider Trans-0.11%Inst Trans1.30%
Short Float2.57%EarningsApr 30/a
Analyst Recom3.15Target Price346.00
Avg Volume691.63K52W Range275.06 - 374.78
ANSYS, Inc. engages in the development and marketing of engineering simulation software and services. The firm's solutions include automotive, aerospace and defense, construction, energy, materials and chemical processing, autonomous engineering, and electrification. The company was founded by John A. Swanson in 1970 and is headquartered in Canonsburg, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dorchak GlendaDirectorApr 14 '25Sale300.0120060,0023,230Apr 15 06:00 PM
GLENDA DORCHAKDirectorApr 14 '25Proposed Sale300.0120060,002Apr 14 04:01 PM
Dorchak GlendaDirectorJan 13 '25Sale336.6220067,3243,430Jan 14 06:00 PM
GLENDA DORCHAKDirectorJan 13 '25Proposed Sale336.6220067,324Jan 13 04:07 PM
Dorchak GlendaDirectorOct 07 '24Sale313.6115247,6693,630Oct 07 06:00 PM
1234567891011